Cardiovascular Drugs Practice Questions

Q: Which antihypertensive is a prodrug and is converted to its active form in the brain?

Methyldopa. **Explanation:** **Methyldopa** is the correct answer because it is a centrally acting antihypertensive that functions as a **prodrug**. After crossing the blood-brain barrier, it is taken up by noradrenergic neurons and converted via the catecholamine synthesis pathway: * Methyldopa → α-methyldopamine → **α-methylnorepinephrine** (the active metabolite). This active form stimulates central **α₂-adrenergic receptors** in the nucleus tractus solitarius, leading to a decrease in sympathetic outflow and a subsequent fall in blood pressure. **Analysis of Incorrect Options:** * **Clonidine:** While also a central α₂-agonist, it is **not a prodrug**. It is active in its original form and directly stimulates the receptors. * **Minoxidil:** This is a potent vasodilator (K⁺ channel opener). While it is a prodrug, it is converted to its active form (minoxidil sulfate) in the **liver**, not the brain. * **Nitroprusside:** This is a direct-acting vasodilator that releases nitric oxide (NO) spontaneously in the blood; it does not require metabolic activation in the brain. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Methyldopa remains a preferred antihypertensive in **pregnancy** (Gestational Hypertension/Preeclampsia). * **Adverse Effects:** Can cause a **positive Direct Coombs Test** (hemolytic anemia), sedation, and drug-induced lupus-like syndrome. * **Mechanism Tip:** Remember "False Neurotransmitter" – α-methylnorepinephrine replaces NE in vesicles but acts as a potent agonist only at inhibitory α₂ receptors.

Q: What is the drug of choice for managing an asthmatic patient with hypertension?

Amlodipine. ### Explanation **Correct Answer: D. Amlodipine** **1. Why Amlodipine is the Drug of Choice:** In patients with **Bronchial Asthma**, the primary goal is to avoid any medication that can trigger bronchospasm. Amlodipine is a **Dihydropyridine Calcium Channel Blocker (CCB)**. It works by causing peripheral vasodilation without affecting the bronchial smooth muscle. Unlike beta-blockers, CCBs do not interfere with $\beta_2$ receptors in the lungs, making them safe and effective for hypertensive patients with co-existing respiratory diseases like asthma or COPD. **2. Why Other Options are Incorrect:** * **Propranolol (Option B):** This is a **non-selective beta-blocker**. It blocks both $\beta_1$ (heart) and $\beta_2$ (bronchioles) receptors. Blocking $\beta_2$ receptors leads to life-threatening bronchoconstriction in asthmatics. It is strictly contraindicated. * **Timolol (Option A):** Also a non-selective beta-blocker. Even when used as eye drops for glaucoma, systemic absorption can trigger severe asthma attacks. * **Metoprolol (Option C):** This is a **cardioselective ($\beta_1$) blocker**. While "safer" than propranolol, selectivity is dose-dependent and is lost at higher doses. In clinical practice and exams, even selective beta-blockers are generally avoided in asthmatics if safer alternatives like CCBs or ACE inhibitors are available. **3. NEET-PG High-Yield Pearls:** * **Preferred Antihypertensives in Asthma:** CCBs (Amlodipine), ACE inhibitors (though watch for "ACE-cough"), and ARBs (Losartan). * **Beta-blocker Contraindications:** Asthma, COPD, 2nd/3rd-degree heart block, and Prinzmetal angina. * **Drug of Choice for Hypertension with Diabetes:** ACE inhibitors (Renoprotective). * **Drug of Choice for Hypertension in Pregnancy:** Labetalol (followed by Methyldopa/Nifedipine).

Q: Acute symptomatic sinus bradycardia usually responds to which of the following medications?

Atropine. **Explanation:** **1. Why Atropine is Correct:** Atropine is the **first-line drug** for acute symptomatic bradycardia. It is a competitive **muscarinic antagonist** that blocks the action of acetylcholine at the M2 receptors in the Sinoatrial (SA) node. By inhibiting the parasympathetic (vagal) tone, it increases the firing rate of the SA node and enhances conduction through the Atrioventricular (AV) node, thereby increasing the heart rate. **2. Why Other Options are Incorrect:** * **Adrenaline (Epinephrine):** While it has potent $\beta_1$ agonist activity that increases heart rate, it is typically reserved for cardiac arrest or as a second-line infusion if atropine and pacing fail. * **Dopamine:** This is a second-line treatment option. It is used as an infusion for bradycardia associated with hypotension, but it is not the initial drug of choice. * **Norepinephrine:** It primarily acts on $\alpha_1$ receptors causing vasoconstriction. While it has some $\beta_1$ activity, the resulting increase in blood pressure often triggers a **reflex bradycardia**, making it unsuitable for treating slow heart rates. **3. NEET-PG High-Yield Pearls:** * **Standard Dose:** 0.5 mg IV every 3–5 minutes (Maximum total dose: 3 mg). * **Paradoxical Effect:** Doses of atropine **< 0.5 mg** can cause "paradoxical bradycardia" due to the blockade of presynaptic inhibitory M1 receptors on vagal nerve endings. * **Ineffectiveness:** Atropine is often ineffective in patients with **Heart Transplants** (denervated hearts) and **Type II Second-degree or Third-degree AV blocks** (where pacing is preferred). * **Drug of Choice for AV block in MI:** Atropine is specifically preferred for bradycardia/AV block occurring in **Inferior Wall MI** (due to high vagal tone).

Q: Which of the following antilipidemic drugs reduces cholesterol levels by decreasing cholesterol absorption in the intestine by acting on NPC1L1 receptors?

Fenofibrate. **Explanation:** The question asks for the drug that inhibits cholesterol absorption via the **NPC1L1 (Niemann-Pick C1-Like 1)** protein. **Note on the Answer Key:** There appears to be a discrepancy in the provided key. **Ezetimibe (Option D)** is the classic and specific inhibitor of the NPC1L1 transporter. **Fenofibrate (Option A)** is a PPAR-α agonist and does not act on NPC1L1. **1. Why Ezetimibe is the correct mechanism-based answer:** Ezetimibe selectively inhibits the **NPC1L1 receptor** located on the brush border of enterocytes in the small intestine. This action blocks the absorption of both dietary and biliary cholesterol. By reducing the delivery of intestinal cholesterol to the liver, it upregulates LDL receptors, leading to a reduction in serum LDL-C levels. **2. Why the other options are incorrect:** * **Fenofibrate (Option A):** A Fibrate that activates **PPAR-α** (Peroxisome Proliferator-Activated Receptor-alpha). Its primary effect is to increase LPL (Lipoprotein Lipase) activity, significantly lowering triglycerides. * **Nicotinic Acid (Option B):** Inhibits the lipolysis of triglycerides in adipose tissue by acting on G-protein coupled receptors, thereby reducing VLDL and LDL synthesis. * **Lovastatin (Option C):** A Statin that competitively inhibits **HMG-CoA reductase**, the rate-limiting enzyme in hepatic cholesterol synthesis. **High-Yield NEET-PG Pearls:** * **Ezetimibe** is often used as an "add-on" to statin therapy (synergistic effect). * **NPC1L1** is the specific molecular target for Ezetimibe. * **Side Effects:** Ezetimibe is generally well-tolerated but may cause reversible hepatic impairment when combined with statins. * **Drug of Choice for Hypertriglyceridemia:** Fibrates (like Fenofibrate). * **Drug of Choice for Hypercholesterolemia:** Statins.

Q: Which enzymes activate prodrugs of ACE inhibitors to their active form?

Esterases. **Explanation:** Most ACE inhibitors (ACEIs) are formulated as **prodrugs** to improve their oral bioavailability and lipid solubility. These prodrugs are esters that require metabolic activation to become pharmacologically active. **1. Why Esterases are correct:** The conversion of an ACE inhibitor prodrug (e.g., Enalapril) into its active metabolite (e.g., Enalaprilat) occurs primarily in the **liver** via **hepatic esterases**. These enzymes hydrolyze the ester bond, releasing the active carboxylic acid form which can then bind to the Angiotensin Converting Enzyme. **2. Analysis of Incorrect Options:** * **Amidases:** These enzymes hydrolyze amide bonds. While important for the metabolism of drugs like Lidocaine, they are not involved in the activation of ACEI prodrugs. * **Angiotensin Converting Enzyme (ACE):** This is the *target* of the drug, not the activator. ACEIs inhibit this enzyme to prevent the conversion of Angiotensin I to Angiotensin II. * **Conjugases:** These are involved in Phase II metabolism (e.g., glucuronidation) to make drugs more water-soluble for excretion, rather than the initial activation of prodrugs. **High-Yield Clinical Pearls for NEET-PG:** * **The Exceptions:** All ACE inhibitors are prodrugs **EXCEPT Captopril and Lisinopril**. These two are already active and do not require hepatic activation (useful in patients with severe liver disease). * **Active Metabolites:** Enalapril → Enalaprilat; Ramipril → Ramiprilat; Perindopril → Perindoprilat. * **Excretion:** Most ACEIs are excreted renally. **Fosinopril** and **Moexipril** are unique as they have significant biliary excretion, making them safer in patients with renal impairment. * **Side Effects:** Remember the mnemonic **CAPTOPRIL** (Cough, Angioedema, Proteinuria, Taste changes, Orthostatic hypotension, Pregnancy contraindication, Renal artery stenosis contraindication, Increased potassium, Leukopenia).

Q: Which of the following is NOT a contraindication for digitalis therapy?

Increased intracellular calcium. **Explanation:** Digitalis (Digoxin) works by inhibiting the **Na⁺/K⁺-ATPase pump**, which indirectly leads to an **increase in intracellular calcium** levels. This increase in calcium is the fundamental mechanism responsible for its positive inotropic effect (increased force of contraction). Therefore, increased intracellular calcium is the *intended therapeutic goal*, not a contraindication. **Analysis of Contraindications:** * **Carditis (Option A):** In conditions like acute rheumatic carditis, the myocardium is highly irritable. Digitalis can precipitate severe arrhythmias in an inflamed heart, making it a relative contraindication. * **Atrioventricular (AV) Block (Option C):** Digitalis has potent vagomimetic effects and directly slows conduction through the AV node. In patients with pre-existing heart block, it can worsen the condition, potentially leading to complete heart block. * **Hepatic Failure (Option D):** While Digoxin is primarily excreted renally, **Digitoxin** (another cardiac glycoside) is metabolized by the liver. In the context of general digitalis therapy, hepatic or renal impairment requires extreme caution or avoidance to prevent toxicity due to the drug's narrow therapeutic index. **High-Yield Clinical Pearls for NEET-PG:** * **Hypokalemia** is the most common electrolyte abnormality that predisposes to digitalis toxicity (as K⁺ and Digoxin compete for the same binding site on the Na⁺/K⁺-ATPase pump). * **Hypercalcemia** and **Hypomagnesemia** also increase the risk of digitalis-induced arrhythmias. * **Wolff-Parkinson-White (WPW) Syndrome** is a classic contraindication as digitalis can shorten the refractory period of the accessory pathway, leading to fatal ventricular rates. * **Digibind** (Digoxin-specific antibody fragments) is the antidote for life-threatening toxicity.

Q: Niacin should be avoided in patients with which of the following conditions?

Peptic ulcer. **Explanation:** **Niacin (Nicotinic Acid)** is a lipid-lowering agent that inhibits the mobilization of free fatty acids from peripheral adipose tissue. While effective at increasing HDL levels, it has a distinct side-effect profile that dictates its contraindications. **Why Peptic Ulcer is the Correct Answer:** Niacin stimulates the release of **histamine**, which leads to an increase in gastric acid secretion via H2 receptors. This can exacerbate or reactivate a **peptic ulcer**. Therefore, active peptic ulcer disease is a relative contraindication for Niacin therapy. Additionally, Niacin is known to cause significant GI irritation and dyspepsia. **Analysis of Incorrect Options:** * **Hypertension:** Niacin actually causes peripheral vasodilation (mediated by Prostaglandin D2 and E2), which can lead to a slight *decrease* in blood pressure. It is not contraindicated in hypertensive patients. * **Alzheimer’s Disease & Parkinsonism:** Niacin has no known adverse interactions with the pathophysiology or treatment of these neurodegenerative conditions. In fact, some research suggests B-complex vitamins may have a supportive role in neurological health. **High-Yield Clinical Pearls for NEET-PG:** * **Cutaneous Flushing:** The most common side effect, mediated by **Prostaglandins**. It can be prevented by taking **Aspirin** 30 minutes before Niacin. * **Metabolic Effects:** Niacin causes **Hyperuricemia** (can precipitate Gout) and **Hyperglycemia** (should be used cautiously in Diabetics). * **Hepatotoxicity:** It is the most serious side effect, especially with sustained-release formulations. * **Acanthosis Nigricans:** A unique dermatological side effect associated with high-dose Niacin.

Q: A patient presents to the emergency department following a drug overdose, exhibiting severe tachycardia. The patient was previously on therapy for hypertension and angina. Which of the following medications can cause tachycardia?

Isosorbide dinitrate. The correct answer is **Isosorbide dinitrate (Option B)**. **Mechanism of Action:** Isosorbide dinitrate is a nitrate that acts as a potent vasodilator. It primarily causes venodilation (reducing preload) and, at higher doses, arterial dilation (reducing afterload) [1]. This sudden drop in systemic blood pressure triggers a **baroreceptor-mediated reflex increase in sympathetic outflow**, leading to **reflex tachycardia** [3]. This is a classic compensatory mechanism seen with rapidly acting vasodilators. **Analysis of Incorrect Options:** * **Guanethidine (A):** This is an adrenergic neuron blocker that inhibits the release of norepinephrine. It typically causes bradycardia and orthostatic hypotension, not tachycardia. * **Propranolol (C):** A non-selective beta-blocker ($ \beta_1$ and $\beta_2$). By blocking $\beta_1$ receptors in the heart, it decreases the heart rate (**bradycardia**) and myocardial contractility [4]. * **Verapamil (D):** A non-dihydropyridine calcium channel blocker (CCB) with significant negative chronotropic and inotropic effects. It acts directly on the SA and AV nodes to cause **bradycardia**; its interaction with beta-blockers can further worsen this effect [4]. **High-Yield NEET-PG Pearls:** * **Reflex Tachycardia:** Common with Nitrates, Hydralazine, and Dihydropyridine CCBs (e.g., Nifedipine) [1], [2]. * **Clinical Correlation:** To prevent reflex tachycardia and "steal phenomenon," nitrates are often co-administered with beta-blockers (like Propranolol) in angina patients. * **Contraindication:** Avoid using Nitrates in patients taking Sildenafil (PDE-5 inhibitors) due to the risk of life-threatening hypotension [1]. * **Drug of Choice:** For nitrate-induced tachycardia, the drug of choice is a beta-blocker.

Question 1

Which antihypertensive is a prodrug and is converted to its active form in the brain?

Accepted Answer

Methyldopa

Answer

Clonidine

Answer

Minoxidil

Answer

Nitroprusside

Question 2

What is the drug of choice for managing an asthmatic patient with hypertension?

Accepted Answer

Amlodipine

Answer

Timolol

Answer

Propranolol

Answer

Metoprolol

Question 3

The beneficial effects of nitrates in the treatment of angina include the following except?

Accepted Answer

Decreased diastole perfusion time

Answer

Decreased arterial pressure

Answer

Decreased ventricular volume

Answer

Decreased ejection time

Question 4

Acute symptomatic sinus bradycardia usually responds to which of the following medications?

Accepted Answer

Atropine

Answer

Adrenaline

Answer

Dopamine

Answer

Norepinephrine

Question 5

Which of the following antilipidemic drugs reduces cholesterol levels by decreasing cholesterol absorption in the intestine by acting on NPC1L1 receptors?

Accepted Answer

Fenofibrate

Answer

Nicotinic acid

Answer

Lovastatin

Answer

Ezetimibe

Question 6

Which enzymes activate prodrugs of ACE inhibitors to their active form?

Accepted Answer

Esterases

Answer

Amidases

Answer

Angiotensin converting enzyme

Answer

Conjugases

Question 7

Which of the following is NOT a contraindication for digitalis therapy?

Accepted Answer

Increased intracellular calcium

Answer

Carditis

Answer

Atrioventricular block

Answer

Hepatic failure

Question 8

Niacin should be avoided in patients with which of the following conditions?

Accepted Answer

Peptic ulcer

Answer

Hypertension

Answer

Alzheimer's disease

Answer

Parkinsonism

Question 9

Which of the following enzymes metabolizes nitrates to produce nitric oxide (NO)?

Accepted Answer

Aldehyde dehydrogenase

Answer

Alcohol dehydrogenase

Answer

Nitrate reductase

Answer

Phosphodiesterase-5

Question 10

A patient presents to the emergency department following a drug overdose, exhibiting severe tachycardia. The patient was previously on therapy for hypertension and angina. Which of the following medications can cause tachycardia?

Accepted Answer

Isosorbide dinitrate

Answer

Guanethidine

Answer

Propranolol

Answer

Verapamil

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?